Home
Live Updates
Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting : comparemela.com
Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision oncology company focused on developing and commercializing therapies for...
Related Keywords
United States ,
American ,
Aadi Bioscience ,
Loretta Itri ,
Shihe Hou ,
Lauren Dockery ,
Prnewswire Aadi Bioscience Inc ,
Linkedin ,
American Society Of Clinical Oncology ,
Nasdaq ,
Twitter ,
Clinical Oncology ,
American Society ,
Annual Meeting ,
Chief Medical Officer ,
Poster Session ,
Looking Statements ,
Private Securities Litigation Reform Act ,
Annual Report ,
Quarterly Reports ,
comparemela.com © 2020. All Rights Reserved.